Stock Updates

Is this Large Market Cap Stock target price reasonable for Teva Pharmaceutical Industries Limited (NYSE:TEVA)?

The company in question is, Teva Pharmaceutical Industries Limited (NYSE:TEVA) currently with a stock price of 53.52 (-1.27% today). The market cap for Teva Pharmaceutical Industries Limited is 52511.06, and is in the sector Healthcare, and Drug Manufacturers – Other industry. The target price for Teva Pharmaceutical Industries Limited is 70.29. Currently Teva Pharmaceutical Industries Limited is trading with a P/E of 28.22, and a forward P/E of 9.02. Average volume for Teva Pharmaceutical Industries Limited is 5993.2 and so far today it is 1831948.

Performance in the last year for Teva Pharmaceutical Industries Limited has been -21.21%. For EPS growth, Teva Pharmaceutical Industries Limited has seen a growth of -48.90%, and is looking to grow in the next year to 13.33%. More long term stats show that EPS growth has been -13.10% over the last five years and could be 4.97% for the next five years. Teva Pharmaceutical Industries Limited has seen sales growth quarter over quarter at -3.50%, with EPS growth quarter over quarter at 19.10%. The 20-day simple moving average is 1.54%, with the 200-day simple moving average coming to -5.72%.

Since the IPO date for Teva Pharmaceutical Industries Limited on the 3/26/1990, Teva Pharmaceutical Industries Limited has seen performance year to date to be -16.36%. With Teva Pharmaceutical Industries Limited trading at 53.52, the dividend yield is 2.51%, and the EPS is 1.92.

So could Teva Pharmaceutical Industries Limited, be undervalued? Well as said before P/E is 28.22. The PEG is 5.67, P/S is 2.7 and the P/B is at 1.63. The P/cash is 8.8, with P/free cash flow at *TBA.

Teva Pharmaceutical Industries Limited ability to deal with debt shows that the current ratio is 1.3, and the quick ratio is 1. This is with long term debt/equity at 0.28, and total debt/equity at 0.34.

In terms of margins, Teva Pharmaceutical Industries Limited has a gross margin of 58.10%, an operating margin of 19.30% and a profit margin of 8.70%.Payout ratio for Teva Pharmaceutical Industries Limited is 70.10%. Return on assets come to 3.30% with return on investment coming to 5.70%.

Insider ownership for Teva Pharmaceutical Industries Limited, is at 2.70% and institutional ownership comes to 67.70%. Outstanding shares are at 968.66. While shares float is 968.66. The float short is currently 2.31%, and short ratio is 3.73.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Stephen Butters

Leave a Comment